Back to Market Feed

Historical record - last NADAC effective date: 7/17/2024

Product Information

TIROSINT 44 MCG CAPSULE is a brand product labeled by IBSA Pharma Inc., priced at $4.5263 per EA under NDC 71858001304. Its NADAC has been published 12 times since Jul 17, 2024.

FDA first approved this application on Oct 13, 2006.

The High Outlier badge above means this manufacturer's average price in the levothyroxine sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TIROSINT 44 MCG CAPSULE

levothyroxine sodium
$4.5263per EA
High Outlier

Strength

44 ug/1

Manufacturer

IBSA Pharma Inc.

NDC

71858001304

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Effective Date

7/17/2024

Active Ingredients

LEVOTHYROXINE SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA021924

FDA Approved

10/13/2006

On Market Since

3/1/2023

Pharmacological Classes

Thyroxine
l-Thyroxine

Price Statistics

The NADAC for TIROSINT 44 MCG CAPSULE has been published 12 times since Jul 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$4.5263 per EA
All-time high$4.5263 (Oct 2, 2024)
All-time low$4.5263 (Jul 17, 2024)
Median price$4.5263
Average price$4.5263
Largest weekly change0.0% (Jul 24, 2024)
Weeks tracked12
Tracking sinceJul 17, 2024

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

0.0%

Last surveyed Oct 2, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the levothyroxine sodium market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

THYQUIDITY 100 MCG/5 ML SOLN
Brand
82685036002•Oliva Therapeutics, LLC
$1.3844
per ML
SYNTHROID 300 MCG TABLET
Brand
00074714919•AbbVie Inc.
$1.6563
per EA
SYNTHROID 300 MCG TABLET
Brand
00074714990•AbbVie Inc.
$1.6563
per EA
SYNTHROID 200 MCG TABLET
Brand
00074714811•AbbVie Inc.
$1.6577
per EA
SYNTHROID 200 MCG TABLET
Brand
00074714819•AbbVie Inc.
$1.6577
per EA
SYNTHROID 200 MCG TABLET
Brand
00074714890•AbbVie Inc.
$1.6577
per EA
SYNTHROID 175 MCG TABLET
Brand
00074707019•AbbVie Inc.
$1.6592
per EA
SYNTHROID 175 MCG TABLET
Brand
00074707090•AbbVie Inc.
$1.6592
per EA
SYNTHROID 25 MCG TABLET
Brand
00074434119•AbbVie Inc.
$1.6593
per EA
SYNTHROID 25 MCG TABLET
Brand
00074434190•AbbVie Inc.
$1.6593
per EA

Frequently asked questions

What is the NADAC price of TIROSINT 44 MCG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TIROSINT 44 MCG CAPSULE, manufactured by IBSA Pharma Inc., is $4.5263 per EA (NDC 71858001304), effective Oct 2, 2024.

How has the price of TIROSINT 44 MCG CAPSULE changed over time?

Over the history we have for it, the NADAC for TIROSINT 44 MCG CAPSULE has held within roughly two percent of its current level. It has been tracked across 12 weekly CMS publications since Jul 17, 2024.

What are the highest and lowest recorded NADAC prices for TIROSINT 44 MCG CAPSULE?

Since Jul 17, 2024, the NADAC for TIROSINT 44 MCG CAPSULE has ranged from a low of $4.5263 (Jul 17, 2024) to a high of $4.5263 (Oct 2, 2024), with a median of $4.5263 per EA.

Are there cheaper alternatives to TIROSINT 44 MCG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of TIROSINT 44 MCG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures TIROSINT 44 MCG CAPSULE?

TIROSINT 44 MCG CAPSULE (NDC 71858001304) is labeled by IBSA Pharma Inc., and CMS classifies it as a brand product.